Novanta opened lower at $118.96, compared with its previous close of $123.31. In the last trading session, the stock traded between $114.84 and $121.11. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Novanta is now worth
$ 69.70
Resulting in a loss of
$ 30.30 (30.30%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 1 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-6.06 (-4.91%)
Day High
$121.11
Day Low
$114.84
Day Open
$118.96
Prev Close
$123.31
Volume
7,66,339
1W Return
-19.41%
1M Return
-18.98%
3M Return
-30.02%
6M Return
-16.23%
1Y Return
9.83%
Fundamentals
Market Cap ($ Mn)
4,435
PE Ratio
90.08
PB Ratio
3.14
PEG Ratio
17.54
ROE
6.07%
ROCE
6.80%
EPS (TTM)
$0.05
Investment Returns
1 Week
-19.41%
1 Month
-18.98%
3 Months
-30.02%
6 Months
-16.23%
9 Months
-17.33%
Financials
Quarterly
All values in $ Mn
247.8
Sep 25
258.3
Dec 25
0.0
Mar 26
257.7
Mar 26
265.8
Jun 26
305.0
Sep 26
Updates
12Nov
Baird lowers Novanta price target to $175, maintains Outperform
Baird analyst Quinn Fredrickson lowered Novanta's price target from $194 to $175. The firm maintained its Outperform rating on the stock. The revision reflects updated valuation assumptions for the company.
Novanta raised FY26 sales guidance to $1.135B-$1.140B, beating the $1.134B estimate. Full-year adjusted EPS guidance lowered to $3.66-$3.71 vs prior $3.68-$3.74. Q3 adjusted EPS of $1.05 beat estimates by 8.25%; revenue rose 23.1% YoY. GAAP net income fell 81.3% due to acquisition-related amortization and costs.
3 days ago
9Oct
Novanta shares deliver 20.4% annualized return over past 15 years
Novanta delivered a 20.4% average annual return over 15 years. Initial $100 investment grew to $1,552.20 at current price of $140.66. Stock outperformed the market by 7.15% on an annualized basis. Current market capitalization stands at $4.86 billion.
1mo ago
29Aug
Novanta CFO, COO to present at Baird Global Healthcare Conference
Novanta Inc. executives to present at Baird Global Healthcare Conference. Robert Buckley, CFO, and John Lesica, COO of Medical Solutions, are speakers. Event scheduled for September 15, 2026, in New York.
2mo ago
22Aug
Novanta stock delivers 23.93% annualized return over last 10 years
Novanta stock delivered a 23.93% average annual return over the past 10 years. The company outperformed the broader market by 10.52% on an annualized basis. A hypothetical $100 investment made a decade ago is now worth $862.47. Novanta currently maintains a market capitalization of $5.17 billion. The data highlights the compounding effect of consistent outperformance.
Novanta Inc. delivered a strong Q2 FY26 performance with adjusted EPS of $0.89 beating estimates, driven by 10.3% YoY revenue growth to $265.8 million. The beat highlights effective execution across its Automation and Medical segments.
